Accelerate Diagnostics (AXDX) Reports In-Line Q3 EPS

Accelerate Diagnostics (NASDAQ: AXDX) reported Q3 EPS of ($0.41), in-line with the analyst estimate of ($0.41). Revenue for the quarter came in at $1.36 million versus the consensus estimate of $2.95 million.

For earnings history and earnings-related data on Accelerate Diagnostics (AXDX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank
• General Mills (GIS) PT Lowered to $42 at Freedom Broker